Literature DB >> 3682765

Pathology of dietary carbonyl iron overload in rats.

C H Park1, B R Bacon, G M Brittenham, A S Tavill.   

Abstract

Serial light microscopic and ultrastructural studies were performed in rats with experimental iron overload produced by dietary supplementation with carbonyl (elemental) iron over a 12-month period. Hepatic iron increased rapidly to concentrations approximately 40 to 90 times those of control rats by 3 months. Within the liver, iron deposition was initially confined to periportal (zone 1) hepatocytes but subsequently extended to midzonal (zone 2) and centrilobular (zone 3) hepatocytes. Reticuloendothelial cell deposits of iron increased gradually and became prominent after 3 months. At this time, morphologic evidence of hepatocellular injury was mild and subtle with occasional foci of spotty necrosis and ultrastructural subcellular organelle damage. By 8 months, iron deposition was massive. Portal areas were enlarged with collections of iron-loaded macrophages and increased collagenous tissue. This portal fibrous tissue extended between periportal (zone 1) hepatocytes at sites of maximal iron deposition and around iron-loaded Kupffer cells and macrophages. At 12 months, the periportal (zone 1) fibrosis was more pronounced. These serial morphologic studies are the first to demonstrate the production of hepatic fibrosis by chronic dietary iron overload. This experimental model may reproduce important components of the pathophysiologic sequence of chronic liver damage seen in iron overload states in humans.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3682765

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  25 in total

1.  Novel assessment of hepatic iron distribution by synchrotron radiation X-ray fluorescence microscopy.

Authors:  Hisoka Kinoshita; Yuichi Hori; Takumi Fukumoto; Takuji Ohigashi; Kunio Shinohara; Yoshitake Hayashi; Yonson Ku
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

2.  Accelerated proliferation of hepatocytes in rats with iron overload after partial hepatectomy.

Authors:  Shucai An; Kyaw Soe; Maki Akamatsu; Yoshitaka Hishikawa; Takehiko Koji
Journal:  Histochem Cell Biol       Date:  2012-07-24       Impact factor: 4.304

3.  Iron overload diminishes atherosclerosis in apoE-deficient mice.

Authors:  E A Kirk; J W Heinecke; R C LeBoeuf
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Effect of iron overload in the isolated ischemic and reperfused rat heart.

Authors:  S Pucheu; C Coudray; N Tresallet; A Favier; J de Leiris
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

5.  Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents.

Authors:  A Pietrangelo; R Gualdi; G Casalgrandi; G Montosi; E Ventura
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.

Authors:  Thomas B Bartnikas; Sheryl J Wildt; Amy E Wineinger; Klaus Schmitz-Abe; Kyriacos Markianos; Dale M Cooper; Mark D Fleming
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

7.  Experimental liver cirrhosis induced by alcohol and iron.

Authors:  H Tsukamoto; W Horne; S Kamimura; O Niemelä; S Parkkila; S Ylä-Herttuala; G M Brittenham
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Effects of experimental hemosiderosis on pancreatic tissue iron content and structure.

Authors:  D Pelot; X J Zhou; P Carpenter; N D Vaziri
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

9.  Hemochromatosis: a model of metal-related human toxicosis.

Authors:  Pierre Brissot; Thibault Cavey; Martine Ropert; François Gaboriau; Olivier Loréal
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-15       Impact factor: 4.223

Review 10.  Transferrin-mediated cellular iron delivery.

Authors:  Ashley N Luck; Anne B Mason
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.